The Lisinopril Tablets, cataloged under National Stock Number 6505-01-416-4018, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Central Sharpening Co Inc. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-416-4018 |
| Primary Part Number | NDC00185-0101-33 |
| Item Name | Lisinopril Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Central Sharpening Co Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 3000.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 10.000 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00185-0101-33 PRIMARY | Central Sharpening Co Inc (USA) |
| Reference | Meaning |
|---|---|
| 95-0414 | 5/1 Secondary reference U.S. Government activity |
| ZESTRIL | 5/9 Secondary reference Astrazeneca Lp |
NSN 6505-01-416-4018 is a Lisinopril Tablets, manufactured by Central Sharpening Co Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-416-4018 has 1 manufacturer part number on file: NDC00185-0101-33 (Central Sharpening Co Inc).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-428-2320. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00185-0101-33: Primary Container Content Quantity: 3000.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: LISINOPRIL TABSELTS USP 10MG 3000S BT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.